Optimizing Medication Reconciliation for Older Veterans in Home Health Care

优化家庭医疗保健中老年退伍军人的药物协调

基本信息

项目摘要

DESCRIPTION (provided by applicant): Medication discrepancies, or differences between what medications patients think they should be taking and the regimen collectively ordered by their healthcare providers, affect up to 70% of patients following hospital discharge. Older Veterans are particularly at risk, owing to multiple comorbidities and complex medication regimens. Frequently there are delays in resolving medication discrepancies, which are major contributors to adverse drug events (ADEs). Among older Veterans 33% experience an ADE in the first few months after hospital discharge, substantially increasing their risk of hospital readmission. Medication reconciliation, the proces of identifying the most accurate list of medications a patient should be taking, is an important strategy to reduce potentially harmful medication discrepancies, thereby improving medication safety. After hospital discharge, home health nurses are well-positioned to perform medication reconciliation; indeed, they are required to document discrepancies and alert the treating physicians. Though more older Veterans are utilizing home health services each year, little is known about the process and effectiveness of resolving medication discrepancies in the home healthcare setting. Currently, there is no standardized approach for home health nurses to identify, prioritize, and communicate discrepancies to the treating physician(s). Furthermore, prolonged time to resolution of discrepancies places older Veterans at increased potential harm due to medications. Therefore, tools to improve medication reconciliation are needed. My long-term career goal is to be an independent investigator whose discoveries improve the processes and outcomes of care transitions for older Veterans. This career development award will allow me to gain greater expertise in hospital discharge transitions and medication reconciliation, advance the methodology in measuring discrepancies, and design and test a pilot intervention to enhance home-based medication reconciliation. The specific aims of the research are to: 1) Observe and document variation in the process of home health medication reconciliation using both qualitative and quantitative methods. I will observe the steps to complete medication reconciliation for older Veterans recently discharged from the hospital in order to document the variation in current practice. 2) With input from relevant health care providers, develop a medication reconciliation protocol for identifying, prioritizing, communicating, and resolving post discharge medication discrepancies in a timely manner. Focus groups will inform development of a protocol to help home health nurses prioritize which medication discrepancies are most clinically important and shape the communication tool to standardize how medication discrepancies are communicated to physicians. 3) Evaluate the feasibility, acceptability, and effectiveness of the reconciliation protocol and communication tool on reducing the time to resolution of post-discharge medication discrepancies. This pilot will set the stage for a larger, more robustly funded study of the intervention's effectiveness. The training program and mentored research activities will achieve the following objectives: a) advance my methodological skills (both qualitative and quantitative) through didactic training and experientia learning; b) gain additional expertise in implementation science and geriatrics through a series of educational experiences, as well as participating in journal clubs and research meetings; and c) develop, implement, and evaluate tools to improve medication safety after hospital discharge with guidance from an interdisciplinary team. All of the award activities will take place in a vibrant and supportive scientific environment grounded in the VA Geriatrics Research and Education Clinical Center (GRECC). In summary, by completing this career development award I will acquire indispensable skills and experience applicable to conducting future translational studies that improve medication safety for older Veterans, thereby possibly reducing hospital readmissions.
描述(由申请人提供): 药物差异,或者患者认为应该服用的药物与医疗保健提供者集体指定的治疗方案之间的差异,会影响出院后高达 70% 的患者。由于多种合并症和复杂的药物治疗方案,老年退伍军人尤其面临风险。药物差异的解决常常出现延误,这是导致药物不良事件 (ADE) 的主要原因。在老年退伍军人中,33% 的人在出院后的头几个月内经历过 ADE,这大大增加了他们再次入院的风险。 药物协调是确定患者应服用的最准确药物清单的过程,是减少潜在有害药物差异的重要策略,从而提高用药安全性。出院后,家庭保健护士可以很好地进行药物协调;事实上,他们需要记录差异并提醒主治医生。尽管每年有越来越多的老年退伍军人利用家庭医疗服务,但人们对解决家庭医疗保健环境中药物差异的过程和有效性知之甚少。目前,家庭保健护士没有标准化的方法来识别、优先考虑差异并向治疗医生传达差异。此外,解决差异的时间较长,使老年退伍军人因药物而面临更大的潜在伤害。因此,需要改进药物协调的工具。 我的长期职业目标是成为一名独立调查员,其发现可以改善老年退伍军人护理过渡的过程和结果。该职业发展奖将使我能够在出院过渡和药物协调方面获得更多专业知识,改进测量差异的方法,并设计和测试试点干预措施以增强家庭药物协调。该研究的具体目标是: 1) 使用定性和定量方法观察并记录家庭健康药物协调过程中的变化。我将观察最近出院的老年退伍军人完成药物协调的步骤,以记录当前实践中的变化。 2) 根据相关医疗保健提供者的意见,制定药物协调方案,用于识别、优先排序、沟通和解决问题 发现用药异常及时出院。焦点小组将告知协议的制定,以帮助家庭保健护士优先考虑哪些药物差异在临床上最重要,并塑造沟通工具以标准化向医生传达药物差异的方式。 3) 评估协调协议和沟通工具在缩短解决出院后药物差异时间方面的可行性、可接受性和有效性。该试点将为更大规模、资金更雄厚的干预措施有效性研究奠定基础。 培训计划和指导研究活动将实现以下目标: a) 通过教学培训和体验式学习提高我的方法技能(定性和定量); b) 通过一系列教育经验以及参加期刊俱乐部和研究会议,获得实施科学和老年病学方面的额外专业知识; c) 在跨学科团队的指导下,开发、实施和评估提高出院后用药安全性的工具。所有奖励活动都将在 VA 老年医学研究和教育临床中心 (GRECC) 充满活力和支持性的科学环境中进行。总之,通过完成这项职业发展奖,我将获得不可或缺的技能和经验,适用于进行未来的转化研究,以提高老年退伍军人的用药安全性,从而可能减少再入院的情况。

项目成果

期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

Amanda Salanitro Mixon其他文献

Amanda Salanitro Mixon的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('Amanda Salanitro Mixon', 18)}}的其他基金

Drug Reduction in Older Patients: The DROP Trial
老年患者减药:DROP 试验
  • 批准号:
    10888125
  • 财政年份:
    2018
  • 资助金额:
    --
  • 项目类别:

相似海外基金

Planar culture of gastrointestinal stem cells for screening pharmaceuticals for adverse event risk
胃肠道干细胞平面培养用于筛选药物不良事件风险
  • 批准号:
    10707830
  • 财政年份:
    2023
  • 资助金额:
    --
  • 项目类别:
Hospital characteristics and Adverse event Rate Measurements (HARM) Evaluated over 21 years.
医院特征和不良事件发生率测量 (HARM) 经过 21 年的评估。
  • 批准号:
    479728
  • 财政年份:
    2023
  • 资助金额:
    --
  • 项目类别:
    Operating Grants
Analysis of ECOG-ACRIN adverse event data to optimize strategies for the longitudinal assessment of tolerability in the context of evolving cancer treatment paradigms (EVOLV)
分析 ECOG-ACRIN 不良事件数据,以优化在不断发展的癌症治疗范式 (EVOLV) 背景下纵向耐受性评估的策略
  • 批准号:
    10884567
  • 财政年份:
    2023
  • 资助金额:
    --
  • 项目类别:
AE2Vec: Medical concept embedding and time-series analysis for automated adverse event detection
AE2Vec:用于自动不良事件检测的医学概念嵌入和时间序列分析
  • 批准号:
    10751964
  • 财政年份:
    2023
  • 资助金额:
    --
  • 项目类别:
Understanding the real-world adverse event risks of novel biosimilar drugs
了解新型生物仿制药的现实不良事件风险
  • 批准号:
    486321
  • 财政年份:
    2022
  • 资助金额:
    --
  • 项目类别:
    Studentship Programs
Pediatric Adverse Event Risk Reduction for High Risk Medications in Children and Adolescents: Improving Pediatric Patient Safety in Dental Practices
降低儿童和青少年高风险药物的儿科不良事件风险:提高牙科诊所中儿科患者的安全
  • 批准号:
    10676786
  • 财政年份:
    2022
  • 资助金额:
    --
  • 项目类别:
Pediatric Adverse Event Risk Reduction for High Risk Medications in Children and Adolescents: Improving Pediatric Patient Safety in Dental Practices
降低儿童和青少年高风险药物的儿科不良事件风险:提高牙科诊所中儿科患者的安全
  • 批准号:
    10440970
  • 财政年份:
    2022
  • 资助金额:
    --
  • 项目类别:
Improving Adverse Event Reporting on Cooperative Oncology Group Trials
改进肿瘤学合作组试验的不良事件报告
  • 批准号:
    10642998
  • 财政年份:
    2022
  • 资助金额:
    --
  • 项目类别:
Planar culture of gastrointestinal stem cells for screening pharmaceuticals for adverse event risk
胃肠道干细胞平面培养用于筛选药物不良事件风险
  • 批准号:
    10482465
  • 财政年份:
    2022
  • 资助金额:
    --
  • 项目类别:
Expanding and Scaling Two-way Texting to Reduce Unnecessary Follow-Up and Improve Adverse Event Identification Among Voluntary Medical Male Circumcision Clients in the Republic of South Africa
扩大和扩大双向短信,以减少南非共和国自愿医疗男性包皮环切术客户中不必要的后续行动并改善不良事件识别
  • 批准号:
    10191053
  • 财政年份:
    2020
  • 资助金额:
    --
  • 项目类别:
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了